Retatrutide vs Tirzepatide.
A side-by-side comparison for laboratory researchers. Both compounds are strictly for research use and are not approved for human or veterinary administration.
Retatrutide
Triple agonist peptide targeting GLP-1, GIP and glucagon receptors. Of interest in metabolic, body-composition and energy-balance research.
Shop Retatrutide →
Tirzepatide
Dual agonist peptide targeting GLP-1 and GIP receptors. A well-characterised reference compound in incretin and metabolism research.
Shop Tirzepatide →FeatureRetatrutideTirzepatide
Receptor profileGLP-1, GIP, glucagon (triple agonist)GLP-1, GIP (dual agonist)
Primary research interestTriple-hormone synergism in metabolic researchDual incretin biology and energy metabolism
Compound classTriple agonist peptideDual agonist peptide
Common analytical testsHPLC-UV, mass spec, endotoxin, identityHPLC-UV, mass spec, endotoxin, identity
Typical lab formLyophilised powder, ≥99% purityLyophilised powder, ≥99% purity
Research contextEmerging candidate for metabolic and body-composition studiesWell-characterised reference in incretin research
Ready to order
Shop the catalogue →